Picture of Bellerophon Therapeutics logo

BLPH — Bellerophon Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Bellerophon Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview

* Bellerophon Therapeutics Inc  BLPH.OQ   BLPH.O  is
expected
to show no change in quarterly revenue when it reports 
results on August 14 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Bellerophon
Therapeutics
Inc is for a loss of 42 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​

This summary was machine generated August 11 at 15:05 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Bellerophon Therapeutics

See all news